Profile of Colorectal Cancer at Sanjiwani General Hospital, Gianyar Period January 2020 – June 2022
DOI:
https://doi.org/10.37275/bsm.v6i15.670Keywords:
Colorectal cancer, Profile, Sanjiwani General HospitalAbstract
Background: Colorectal cancer is one of the most common cancers worldwide and the third leading cause of cancer death in the UK and the United States. There were 1.8 million new colorectal cancer cases and 881,000 deaths. This study aims to determine the profile of colorectal cancer at Sanjiwani General Hospital for the period January 2020 - June 2022.
Methods: This study is a descriptive study using secondary data from archives at the Anatomical Pathology Installation of the Sanjiwani General Hospital for the period January 2020 – June 2022. Data collection in the form of gender, age, cancer location, and histopathological type was carried out using the convenient purposive sampling method.
Results: This study showed that the highest age group was the age group 61-70 years 32.6%, the sex was mostly male 63.9% with the most common location of colorectal cancer found in the rectum 66.2% and the histopathological type in the form of adenocarcinoma 96.5%.
Conclusion: Most of the cases were found in the male gender, and the age range was 61-70 years. Most cancer locations were found in the rectum with the histopathological type of adenocarcinoma.
Authors
- Ni Kadek Seri Mahayanti1*
- I Wayan Eka Saputra2
- 1Internship Doctor, Department of Internal Medicine, Sanjiwani General Hospital, Gianyar, Indonesia
- 2Internist, Department of Internal Medicine, Sanjiwani General Hospital, Gianyar, Indonesia
Corresponding author Ni Kadek Seri Mahayanti — mahayantiseri@yahoo.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
Copyright and licensing
Copyright in each article remains with the author(s). Authors grant Bioscientia Medicina: Journal of Biomedicine and Translational Research a non-exclusive right of first publication and the right to identify itself as the original publisher. No exclusive transfer of copyright is required.
All articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0): https://creativecommons.org/licenses/by-nc-sa/4.0/. Users may copy, redistribute, remix, transform, and build upon the material for non-commercial purposes, provided appropriate attribution is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license.
The license applies to the article's scholarly content unless a credit line states otherwise. Third-party material may be subject to separate rights. Authors retain patent, trademark, moral, and research-data rights. The copyright year follows the article's publication date.
